Shares of Grail, a maker of early-detection cancer screening tests, soared last week. Here are the key chart levels to watch.
The proposal, submitted last week, is a revision of a prior plan the artificial intelligence startup had presented to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback